Reproductive Tourism: Paying Women in Poor Countries to Bear Our Babies is Rife with Ethical Problems
By HealthCanal,
HealthCanal.com
| 10. 23. 2012
By some accounts, the Indian ART industry is worth $500 million to $2.3 billion.
In their upcoming paper, “Ethical concerns for maternal surrogacy and reproductive tourism” in the Journal of Medical Ethics, Professor Raywat Deonandan of the Interdisciplinary School of Health Sciences at the University of Ottawa, along with students Samantha Green and Amanda van Beinum, enumerate the specific ethical challenges posed by this emerging new industry.
Along with six other concerning issues, the authors identified the tension between business ethics and medical ethics as being at the heart of the industry’s ethical problem, along with an insufficiently broad definition of “informed consent.” When desperately poor, illiterate and vulnerable village women are entering into complicated contracts to sell their reproductive health to wealthy foreigners, often some of the softer social risks are not communicated to them, such as their risk of estrangement from their communities, or the risk of domestic unease with their spouses and existing children.
Part of the problem is that when commerce collides with medicine, there isn’t an agreed upon ethical framework for establishing rights and...
Related Articles
By Carl Zimmer, The New York Times | 06.04.2026
Scientists at Columbia University have edited the DNA of early human embryos with unprecedented accuracy, an achievement that could open the way to babies engineered with particular characteristics.
The prospect has fueled controversy for years. On the one hand, the...
By Alexandre Piquard, Le Monde [cites CGS' Katie Hasson] | 05.22.2026
"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of the century." This is how Lucas Harrington explained the goal of his company Preventive: to create genetically modified babies. Trying...
By Jenny Kleeman, The Guardian | 05.30.2026
On a Friday evening in late April, Cathy Tie, the Canadian serial entrepreneur and self-styled “Biotech Barbie”, is centre stage at New York City’s famous Carnegie Hall, performing Saint-Saens’ Piano Concerto No 2 on a gleaming Steinway grand piano, accompanied...
By Virginia Heffernan, The New Republic | 05.29.2026
Here and there, it’s been a good month for humanity—or “magnificas humanitas,” as Pope Leo XIV calls us poor featherless bipeds.
On May 25, the pope published his encyclical letter “on safeguarding the human person in the time of artificial...